Thoratec (THOR) trades up after beating Q1 estimates across the board on stronger sales of its...

|About: Thoratec Corporation (THOR)|By:, SA News Editor

Thoratec (THOR) trades up after beating Q1 estimates across the board on stronger sales of its HeartMate and CentriMag products. The company also raises its FY12 guidance, now expecting an EPS of $1.62 - $1.72 per share on revenue between $452M - $467M. Shares +8.5% AH.